Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Current Oncology Reports
Metadata
Title
New drugs in acute myeloid leukemia
Author
Francis J. Giles, MD
Publication date
01-10-2002
Publisher
Current Medicine Group
Published in
Current Oncology Reports / Issue 5/2002
Print ISSN: 1523-3790
Electronic ISSN: 1534-6269
DOI
https://doi.org/10.1007/s11912-002-0029-8

Other articles of this Issue 5/2002

Current Oncology Reports 5/2002 Go to the issue

OriginalPaper

ziPeripheral T-cell lymphoma

OriginalPaper

Fertility preservation and management of gonadal failure associated with lymphoma therapy

OriginalPaper

Older adults with acute myeloid leukemia

OriginalPaper

Cytogenetics in acute myeloid leukemia

OriginalPaper

Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia

OriginalPaper

Management of acute promyelocytic leukemia
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits